MicroRNAs as potential biomarkers and therapeutic targets in age-related macular degeneration
Age-related macular degeneration (AMD) involves degenerative and neovascular alteration in the macular region of the retina resulting in central vision loss. AMD can be classified into dry (dAMD) and wet AMD (wAMD). There is no established treatment for dAMD, and therapies available for wAMD have li...
Main Authors: | Marisa Cruz-Aguilar, Sergio Groman-Lupa, María C. Jiménez-Martínez |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Ophthalmology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fopht.2023.1023782/full |
Similar Items
-
Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
by: Rachel Hui Fen Lim, et al.
Published: (2017-03-01) -
Circulating microRNAs as biomarkers of Chagas cardiomyopathy
by: Laura Antonietti, et al.
Published: (2023-12-01) -
The regulatory role of microRNAs in common eye diseases: A brief review
by: Javier A. Benavides-Aguilar, et al.
Published: (2023-03-01) -
Circulating MicroRNAs as Novel Potential Diagnostic Biomarkers for Osteosarcoma: A Systematic Review
by: Thaís Borges Gally, et al.
Published: (2021-09-01) -
Differential Circulating MicroRNA Expression in Age-Related Macular Degeneration
by: Hanan ElShelmani, et al.
Published: (2021-11-01)